🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Steatosis of Liver

Spleen Stiffness Measurement for the Detection of Advanced Fibrosis NCT07440511n/a1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS The Development of MASLD Among Survivors of Breast or Colorectal Cancer NCT07280143n/a1 site📍 Bern University of Bern Effectiveness of Bariatric Surgery for NAFLD/NASH NCT04366999n/a1 site📍 Beijing Beijing Friendship Hospital · Tests: SG, RYGB, OAGB Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH) NCT05870969n/a1 site📍 Shanghai Ruijin Hospital · Tests: Liver cancer surveillance every 3 months, Liver cancer surveillance every 6 months, Liver cancer surveillance annually Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study NCT05974904n/a1 site📍 Chongqing Chongqing Medical University · Tests: high-sensitivity C-reactive protein to albumin ratio Multicenter Clinical Study on Noninvasive Assessment of Hepatic Steatosis and Fibrosis Using Visual Transient Elastography NCT07128108n/a1 site📍 Shanghai Xinhua Hospital, Shanghai Jiao Tong University School of Me… · Tests: Visual Transient Elastography (ViTE) Examination Liver Damage and Cardiometabolic Disorders in NAFLD NCT04036357n/a1 site📍 Rome University of Roma La Sapienza Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD NCT07632677n/a22 sites📍 Bengbu📍 Hefei📍 Wuhu The Affiliated Nanjing Drum Tower Hospital of Nanjing Unive… · Tests: iLivTouch (Vibration-controlled transient elastography) Digital Early Warning System for Acute Lung Injury in Liver Surgery NCT07070362n/a4 sites📍 Beijing📍 Beijing📍 Chongqing Beijing Tsinghua Chang Gung Hospital Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease NCT05439226NA3 sites📍 Yichang📍 Changsha📍 Changsha State Key Laboratory of Subhealth Intervention Technology · Tests: CMNT diet Lifestyle Modification in the Treatment of NAFLD. NCT05816915NA1 site📍 Prague General University Hospital, Prague · Tests: Cognitive behavioral therapy Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) NCT04634643n/a1 site📍 New Haven Yale University · Tests: Usual diet and physical activity EVOO and Metabolic Liver Health in MASLD NCT07412444NA1 site📍 Castellana Grotte Azienda Ospedaliera Specializzata in Gastroenterologia Save… · Tests: Oil Supplementation - 3 tablespoons of oil, 9 Tablespoons of Oil A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH NCT06920043Phase 230 sites📍 Chandler📍 Mesa📍 Tucson GlaxoSmithKline · Tests: Efimosfermin, Placebo Global Research Initiative for Patients Screening on MASH NCT05651724n/a13 sites📍 Brussels📍 Antwerp📍 Prague Julius Clinical Evaluation of Gut Permeability in Patients Affected by Obesity and NAFLD: Influence of Ketogenic Diet. NCT05477212NA1 site📍 Castellana Grotte Azienda Ospedaliera Specializzata in Gastroenterologia Save… · Tests: Ketogenic Diet The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction NCT05499702Phase 21 site📍 Rochester Adrian Vella · Tests: Caloric Restriction, Hyperglycemic clamp A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH NCT07221227Phase 391 sites📍 Chandler📍 Tucson📍 Little Rock GlaxoSmithKline · Tests: Efimosfermin alfa, Efimosfermin alfa, Placebo The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) NCT07093346NA3 sites📍 Nottingham📍 Nottingham📍 Nottingham University of Nottingham · Tests: Pectin, Cocoa Powder, Magnetic Resonance Imaging with Contrast Fully Automated High-Throughput Quantitative MRI of the Liver NCT05294471n/a1 site📍 Madison University of Wisconsin, Madison · Tests: Non-contrast MRI with novel MRI software COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study NCT06704516Phase 11 site📍 Oxford University of Oxford · Tests: Menopausal hormone therapy The European NAFLD Registry NCT04442334n/a37 sites📍 Antwerp📍 Helsinki📍 Angers Newcastle University Identification of Liver Fibrosis Biomarkers NCT06819917n/a2 sites📍 Copenhagen📍 Mainz Roche Diagnostics GmbH · Tests: Identification of liver fibrosis biomarkers Study of PNPLA3 Genetic Polymorphisms in Patients With Non-Alcoholic Fatty Liver Disease in an Ultramarine Population (AdipoDROMExpo) NCT07330830n/a3 sites📍 Cayenne📍 Pointe-à-Pitre📍 Saint-Denis Centre Hospitalier Universitaire de la Guadeloupe Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis NCT07270601NA1 site📍 Seattle ContextVision AB · Tests: Verasonics NXT Data Acquisition System, Philips EPIQ Elite, EchoSense FibroScan, Philips 3T Ingenia Elition The COherence of Scatter Identification and Exclusion Algorithm Study NCT06975579n/a1 site📍 London Institute of Cancer Research, United Kingdom · Tests: Ultrasound image processing Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes NCT06989723Phase 41 site📍 Seongnam-si Seoul National University Bundang Hospital · Tests: Pioglitazone 15 MG [Actos], Empagliflozin 10 MG [Jardiance], Empagliflozin 10 MG [Jardiance] + Pioglitazone 15 MG [Acto… Prevention of NAFLD and CVD Through Lifestyle Intervention NCT05618626NA1 site📍 Molina Pontificia Universidad Catolica de Chile · Tests: Physical exercise and dietary intervention for NAFLD A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition NCT05519475Phase 271 sites📍 Flagstaff📍 Peoria📍 Tucson Regeneron Pharmaceuticals · Tests: ALN-HSD, Placebo Comparison Between the Efficacy of Residential and Ambulatory Weight Loss Programs for Pediatric Non-alcoholic Fatty Liver Disease NCT05309863n/a3 sites📍 Ghent📍 Ghent📍 De Haan University Hospital, Ghent · Tests: Lifestyle management
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy